kabutan

SanBio Company Limited <4592> surges in first rebound in 9 days as AKUGO added to NHI drug price list

Thu May 21, 2026 10:34 am JST Catalyst

SanBio Company Limited <4592> rebounded sharply for the first time in nine sessions. After the close of trading on May 20, the company announced that its AKUGO intracerebral implant injection (vandephitemcel) was added to the National Health Insurance (NHI) drug price list the same day. Priced at 72.72 million yen, the drug is indicated for improving chronic motor paralysis associated with traumatic brain injury, acting as a positive catalyst. Additionally, the stock drew bargain-hunting for a technical rebound after entering oversold territory, where its downward divergence from the 25-day moving average temporarily exceeded 26%.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles